Hadassah

Hadassah Pioneer Named Honorary President of International European Liver Congress

Tuesday, Mar 29 2016

Prof. Daniel Shouval, founding head of the Hadassah Medical Center’s Liver Unit.

The European Association for the Study of the Liver (EASL) has named Prof. Daniel Shouval, founding head of the Hadassah Medical Center’s Liver Unit, “Honorary President” of its International Liver Congress™ 2016. The 2016 Conference will take place in Barcelona, April 13-17, with more than 10,000 researchers and physicians from five continents.

EASL's choice expresses recognition of Prof. Shouval's contribution to the understanding and treatment of liver disease in Israel and the world, particularly his work on developing a vaccine for hepatitis B. As a result of Prof. Shouval’s work, Israel was among the first countries to endorse universal vaccination for hepatitis B, a leading cause of liver cancer and liver failure.   Today, 189 of the 194 countries belonging to the World Health Organization recommend this vaccine.

Prof. Shouval was also involved in developing a vaccine for hepatitis A. Israel became the first country to institute universal vaccination for this disease, which was very common in the region. As a result, there was a 95 percent drop in its incidence among children and young adults. The vaccines he and his team created for hepatitis A and B have virtually wiped out these diseases.

In 1983, Prof. Shouval established the first liver unit in Israel at Hadassah, which he directed for almost 30 years until his retirement in 2010. He treated thousands of patients during his   long career at Hadassah, where he was responsible for many breakthroughs, mentored generations of outstanding liver experts, and published pivotal research papers. Today, he continues to teach medicine and to advise the World Health Organization and other health bodies in Europe, Asia, and Africa.

“As someone who has devoted his life to the study of the liver," said Prof. Shouval, “I am very moved at being chosen. More than that, the honor recognizes the work of the outstanding Hadassah liver team that provides hope to patients who had no hope. Furthermore, it recognizes the contribution of the Israeli medical establishment in general, and Hadassah in particular, in finding cures for diseases that threaten such a wide population."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Friday, Jun 22 2018

To Save Their Children - The Mothers Came Secretly From Syria to Hadassah

Repairing the Hearts of Syrian Children at Hadassah Hospital in Jerusalem.

READ MORE ›
alt_text

Thursday, Jun 21 2018

Traveling with Ruth

Ruth Radiano, Head Nurse at Hadassah Hospital Mount Scopus, is an extraordinary woman, whose resume reads like a novel. I recently had the distinct pleasure of meeting her and hearing her speak, and in just five minutes with her, I felt as though I was with a Hadassah sister.

READ MORE ›
alt_text

Wednesday, Jun 20 2018

First in Israel: Hadassah Uses Innovative Technology to Treat Cancer in Spine

A multidisciplinary team at Hadassah Hospital Ein Kerem recently employed an innovative technology to treat cancer metastases near the spinal cord--a first for Israel.

READ MORE ›
alt_text

Tuesday, Jun 19 2018

American Journal of Ophthalmology Article Celebrates the Centennial of Hadassah Ophthalmology

The centennial anniversary of the Hadassah Medical Organization's Department of Ophthalmology is celebrated in the May issue of the American Journal of Ophthalmology, with an article by the immediate past director, Prof. Jacob Pe'er, and the current director, Prof. Itay Chowers.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More